Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/4/2025

IV Lorazepam Dosing for Acute Anxiety

Special Considerations

  • Elderly patients have decreased drug metabolism and higher risk of respiratory depression, requiring lower doses, according to Praxis Medical Insights 1

Critical Safety Monitoring

  • Oxygen supplementation is required due to the primary concern of respiratory depression, as stated in Pediatrics 2
  • Continuous oxygen saturation monitoring is necessary, as recommended by Praxis Medical Insights 3
  • Blood pressure may decrease, particularly with rapid administration, as noted in Pediatrics 2 and Praxis Medical Insights 1

Drug Interactions Requiring Dose Reduction

  • There is an increased risk of apnea when combined with other sedative agents, as reported in Pediatrics 2 and Praxis Medical Insights 4

Common Pitfalls to Avoid

  • Rapid administration increases the risk of hypotension, bradycardia, and respiratory depression, as warned in Pediatrics 2
  • The oral route should not be used post-procedure due to decreased responsiveness, which creates an aspiration risk, as stated in Praxis Medical Insights 3

Reversal Agent Availability

  • Flumazenil should be available to reverse life-threatening respiratory depression, as recommended by Praxis Medical Insights 3 and 1
  • Flumazenil will reverse all benzodiazepine effects and may precipitate withdrawal or seizures in dependent patients, as noted in Praxis Medical Insights 3

REFERENCES

1

Intramuscular Lorazepam Dosing for Seizure Activity in Elderly Patients [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Seizure Management with Lorazepam [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Diazepam and Lorazepam Equivalence and Clinical Considerations [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025